Does real-world evidence have a place in regulatory decision-making? An interview with David Klonoff

Written by The Evidence Base

In this feature, as part of our editorial ‘In focus’ surrounding the regulatory use of real-world evidence (RWE), David Klonoff (Diabetes Research Institute, Mills-Peninsula Medical Center, CA, USA) discusses the benefits and challenges of utilizing RWE in regulatory decision-making. Please could you introduce yourself? I am an endocrinologist by training and am the current Medical Director of the Diabetes Research Institute at the Mills-Peninsula Medical Center (CA, USA), where I have acted as Principal Investigator of 120 clinical trials of diabetes devices and drugs. I am also a Clinical Professor of Medicine at the University of California, San Francisco (CA,...

To view this content, please register now for access

It's completely free